MX9306125A - Composiciones farmaceuticas que contienen agentes tensioactivos no ionicos. - Google Patents
Composiciones farmaceuticas que contienen agentes tensioactivos no ionicos.Info
- Publication number
- MX9306125A MX9306125A MX9306125A MX9306125A MX9306125A MX 9306125 A MX9306125 A MX 9306125A MX 9306125 A MX9306125 A MX 9306125A MX 9306125 A MX9306125 A MX 9306125A MX 9306125 A MX9306125 A MX 9306125A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing non
- ionic surface
- surface agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95596292A | 1992-10-02 | 1992-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9306125A true MX9306125A (es) | 1994-04-29 |
Family
ID=25497602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9306125A MX9306125A (es) | 1992-10-02 | 1993-10-01 | Composiciones farmaceuticas que contienen agentes tensioactivos no ionicos. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0662826A1 (OSRAM) |
| JP (1) | JPH07507565A (OSRAM) |
| KR (1) | KR950703333A (OSRAM) |
| AU (1) | AU5095393A (OSRAM) |
| CA (1) | CA2145763A1 (OSRAM) |
| FI (1) | FI934317L (OSRAM) |
| HU (1) | HUT69400A (OSRAM) |
| IL (1) | IL107084A0 (OSRAM) |
| MX (1) | MX9306125A (OSRAM) |
| TW (1) | TW253838B (OSRAM) |
| WO (1) | WO1994007472A1 (OSRAM) |
| ZA (1) | ZA937268B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1808897A (en) * | 1995-12-13 | 1997-07-03 | Dullatur Limited | A calcitonin preparation |
| SE9602145D0 (sv) * | 1996-05-31 | 1996-05-31 | Astra Ab | New improved formulation for treatment of thromboembolism |
| JP5300477B2 (ja) * | 2006-08-01 | 2013-09-25 | 大塚製薬株式会社 | 薬理活性物質の吸収性が改善された医薬組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1090703B (it) * | 1976-12-03 | 1985-06-26 | Scherer Ltd R P | Perfezionamento nelle composizioni utili quali veicolo per farmaci |
| JPS6233128A (ja) * | 1985-08-07 | 1987-02-13 | Toray Ind Inc | インタ−フエロン腸溶性経口用製剤 |
| ES2045276T3 (es) * | 1988-07-21 | 1994-01-16 | Hoffmann La Roche | Preparacion de insulina |
| AU1256692A (en) * | 1991-02-06 | 1992-09-07 | Schering Corporation | Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor |
| CA2125400A1 (en) * | 1991-12-18 | 1993-06-24 | Gordon L. Amidon | Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
-
1993
- 1993-09-02 CA CA002145763A patent/CA2145763A1/en not_active Abandoned
- 1993-09-02 EP EP93920391A patent/EP0662826A1/en not_active Withdrawn
- 1993-09-02 WO PCT/US1993/008107 patent/WO1994007472A1/en not_active Ceased
- 1993-09-02 KR KR1019950701257A patent/KR950703333A/ko not_active Ceased
- 1993-09-02 AU AU50953/93A patent/AU5095393A/en not_active Abandoned
- 1993-09-02 JP JP6509047A patent/JPH07507565A/ja active Pending
- 1993-09-10 TW TW082107450A patent/TW253838B/zh active
- 1993-09-23 IL IL107084A patent/IL107084A0/xx unknown
- 1993-09-30 ZA ZA937268A patent/ZA937268B/xx unknown
- 1993-09-30 HU HU9302774A patent/HUT69400A/hu unknown
- 1993-10-01 MX MX9306125A patent/MX9306125A/es unknown
- 1993-10-01 FI FI934317A patent/FI934317L/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0662826A1 (en) | 1995-07-19 |
| IL107084A0 (en) | 1993-12-28 |
| CA2145763A1 (en) | 1994-04-14 |
| HU9302774D0 (en) | 1993-12-28 |
| WO1994007472A1 (en) | 1994-04-14 |
| JPH07507565A (ja) | 1995-08-24 |
| FI934317A0 (fi) | 1993-10-01 |
| TW253838B (OSRAM) | 1995-08-11 |
| AU5095393A (en) | 1994-04-26 |
| ZA937268B (en) | 1995-03-30 |
| HUT69400A (en) | 1995-09-28 |
| FI934317A7 (fi) | 1994-04-03 |
| FI934317L (fi) | 1994-04-03 |
| KR950703333A (ko) | 1995-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26671A1 (fr) | COMPOSITION PHARMACEUTIQUE POUVANT eTRE ADMINISTRÉE PAR VOIE ORALE CONTENANT UN INHIBITEUR DE LIPASE GASTRO-INTESTINALE, UN (OU PLUSIEURS) ADDITIF(S) DU GROUPE CONSTITUE PAR LES ÉPAISSISSANTS, ET ÉMULSIFIANTS DE QUALITÉ ALIMENTAIRE MÉDIOCREMENT DIGESTIBLES, MÉDIOCREMENT FERMENTABLES, HYDROPHILES ET OU HYDROCOLLOiDAUX ET DES EXCIPIENTS AUXILIAIRES | |
| ES2153836T3 (es) | Composicion enmascaradora del sabor de agentes farmaceuticos amargos. | |
| CO5700797A2 (es) | Composicion de farmaco conjugado | |
| MX9304775A (es) | Benzoxazinonas como inhibidores de hiv transcriptasa inversa. | |
| NO904729D0 (no) | Nye bakteriocinsammensetninger for anvendelse som bredspektrede baktericider og fremgangsmaater for forhindring og behandling av mikrobielle infeksjoner. | |
| ES2160631T3 (es) | Composiciones de retinoides para aplicacion topica. | |
| ES2125251T3 (es) | Inhibidores de la proteasa del vih. | |
| MY122621A (en) | Compositions containing a high percent saturation concentration of antibacterial agent | |
| MX9710206A (es) | Composicion farmaceutica de amiodarone para administracion parenteral. | |
| KR890004709A (ko) | 항원충제로서의 아지트로마이신 및 이의 유도체 | |
| NO20000314L (no) | Farmasøytiske sammensetninger som inneholder lysostafin alene eller i kombinasjon med et antibiotika for behandling av stafylokokkinfeksjoner | |
| CO4950538A1 (es) | Composiciones farmaceuticas de la tizoxadina y la nitazoxadina | |
| FI962488A0 (fi) | HIV:n proteaasin inhibiittoreita | |
| ES2178200T3 (es) | Conservante para lentes de contacto, solido y soluble en agua. | |
| ES2092559T3 (es) | Formulacion farmaceutica que contiene penciclovir. | |
| NO951265L (no) | Farmasöytiske preparater inneholdende ikke-ioniske overflateaktive midler | |
| DK0497906T3 (da) | L-alfa-glycerophosphoryl-D-myo-inositol til behandling af perifere neuropatier og cerebropatier | |
| CO4600680A1 (es) | Procedimientos para la prevencion de la degradacion de la proteina c | |
| AR013758A1 (es) | Terapia de combinacion para el tratamiento de sida. | |
| AR005730A1 (es) | Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato. | |
| KR950703333A (ko) | 비이온계 계면활성제 함유 약학 조성물(Pharmaceutical Compositions Containing Nonionic Surfactants) | |
| MX9701121A (es) | Combinacion inhibidora de proteasa de vih. | |
| KR970703770A (ko) | 사람 면역결핍 바이러스 감염에 대한 배합 치료(Combination therapy for HIV infection) | |
| ECSP951565A (es) | Composiciones farmaceuticas | |
| ECSP961660A (es) | Terapia combinada para infeccion por vih |